129
Participants
Start Date
June 30, 2009
Primary Completion Date
October 31, 2013
Study Completion Date
August 31, 2015
Temozolomide/Hycamtin (Topotecan)
"Temozolomide: bottles containing 5 capsules of 5, 20, 100 and 250 mg~Hycamtin (Topotecan): a lyophilisate for infusion in vials containing 4 mg~Patients receive during 5 days (Day 1 to Day 5):~Temozolomide 150 mg/m2/day per os, dose will be adjusted to the closest 5 mg, followed one hour later by Hycamtin(Topotecan) 0.75 mg/m2/day as an intravenous infusion over 30 minutes"
Institut Gustave Roussy, Villejuif
Collaborators (1)
St. Anna Kinderkrebsforschung
OTHER
Catholic University of the Sacred Heart
OTHER
Erasmus Medical Center
OTHER
Gustave Roussy, Cancer Campus, Grand Paris
OTHER